These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7940998)

  • 41. Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?
    von Lubitz DK; Ye W; McClellan J; Lin RC
    Ann N Y Acad Sci; 1999; 890():93-106. PubMed ID: 10668416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenosine A3 receptor and brain. A culprit, a hero, or merely yet another receptor?
    von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():49-67. PubMed ID: 9369974
    [No Abstract]   [Full Text] [Related]  

  • 43. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mast cell degranulation following adenosine A3 receptor activation in rats.
    Fozard JR; Pfannkuche HJ; Schuurman HJ
    Eur J Pharmacol; 1996 Mar; 298(3):293-7. PubMed ID: 8846829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
    J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FcepsilonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors.
    Nunomura S; Gon Y; Yoshimaru T; Kashiwakura J; Kawakami T; Ra C
    Eur J Immunol; 2010 Apr; 40(4):1205-17. PubMed ID: 20101614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenosine A3 receptor-mediated airway microvascular leakage: role of mast cells and tachykinins.
    Nagano Y; Tamaoki J; Nishimura K; Yamawaki I; Nagai A
    Res Commun Mol Pathol Pharmacol; 2000; 108(1-2):96-107. PubMed ID: 11758979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of the A3 adenosine receptor gene in vascular smooth muscle cells: role of a cAMP and GATA element.
    Yaar R; Cataldo LM; Tzatsos A; Francis CE; Zhao Z; Ravid K
    Mol Pharmacol; 2002 Nov; 62(5):1167-76. PubMed ID: 12391281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of adenosine for IgE receptor-dependent degranulation of human peripheral basophils and skin mast cells.
    Matsuo Y; Yanase Y; Irifuku R; Ishii K; Kawaguchi T; Takahagi S; Hide I; Hide M
    Allergol Int; 2018 Oct; 67(4):524-526. PubMed ID: 29703695
    [No Abstract]   [Full Text] [Related]  

  • 51. Generation of adenosine A3 receptor functionally humanized mice for the evaluation of the human antagonists.
    Yamano K; Inoue M; Masaki S; Saki M; Ichimura M; Satoh M
    Biochem Pharmacol; 2006 Jan; 71(3):294-306. PubMed ID: 16300745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine A2B receptors: a novel therapeutic target in asthma?
    Feoktistov I; Polosa R; Holgate ST; Biaggioni I
    Trends Pharmacol Sci; 1998 Apr; 19(4):148-53. PubMed ID: 9612090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice.
    Zhong H; Chunn JL; Volmer JB; Fozard JR; Blackburn MR
    J Pharmacol Exp Ther; 2001 Aug; 298(2):433-40. PubMed ID: 11454903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.
    Fishman P; Bar-Yehuda S; Farbstein T; Barer F; Ohana G
    J Cell Physiol; 2000 Jun; 183(3):393-8. PubMed ID: 10797314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells.
    Marquardt DL; Walker LL; Heinemann S
    J Immunol; 1994 May; 152(9):4508-15. PubMed ID: 8157966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cloning and characterisation of the human adenosine A3 receptor gene.
    Murrison EM; Goodson SJ; Edbrooke MR; Harris CA
    FEBS Lett; 1996 Apr; 384(3):243-6. PubMed ID: 8617363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of p42/p44 mitogen-activated protein kinase by the human adenosine A3 receptor in transfected CHO cells.
    Graham S; Combes P; Crumiere M; Klotz KN; Dickenson JM
    Eur J Pharmacol; 2001 May; 420(1):19-26. PubMed ID: 11412835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
    Phelps PT; Anthes JC; Correll CC
    Eur J Pharmacol; 2006 Apr; 536(1-2):28-37. PubMed ID: 16581066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue distribution of adenosine receptor mRNAs in the rat.
    Dixon AK; Gubitz AK; Sirinathsinghji DJ; Richardson PJ; Freeman TC
    Br J Pharmacol; 1996 Jul; 118(6):1461-8. PubMed ID: 8832073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of mast cells by immunoglobulin E-receptor cross-linkage, but not through adenosine receptors, induces A1 expression and promotes survival.
    Möller C; Xiang Z; Nilsson G
    Clin Exp Allergy; 2003 Aug; 33(8):1135-40. PubMed ID: 12911789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.